Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Reinvestment Rate of 0.29x as of June 2023, reinvesting €601.56 Million (capex €524.46 Million plus investments €77.10 Million) from operating cash flow of €2.10 Billion. Explore GU5 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 12 annual periods. Also explore Guangzhou Baiyunshan Pharmaceutical Hold asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For live market cap and broader valuation context, see market cap of Guangzhou Baiyunshan Pharmaceutical Hold.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.73x | €5.96 Billion | €3.44 Billion | €1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | €4.74 Billion | €4.10 Billion | €1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | €7.62 Billion | €7.00 Billion | €1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | €1.30 Billion | €5.67 Billion | €1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | €1.39 Billion | €585.19 Million | €876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | €3.63 Billion | €5.02 Billion | €2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | €909.71 Million | €5.22 Billion | €478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | €2.57 Billion | €1.83 Billion | €196.77 Million | ▲ +646.4% |
| 2016 | 0.19x | €477.18 Million | €2.54 Billion | €228.03 Million | ▼ -54.5% |
| 2015 | 0.41x | €800.01 Million | €1.94 Billion | €515.34 Million | ▲ +12.3% |
| 2014 | 0.37x | €641.36 Million | €1.75 Billion | €356.70 Million | ▲ +38.3% |
| 2013 | 0.27x | €354.40 Million | €1.34 Billion | €350.35 Million | — |